药物对比
Propoxyphene vs Lasmiditan
比较已撤市的阿片类药物 Propoxyphene 与 Lasmiditan（Reyvow）在偏头痛和疼痛治疗中的差异。作用方式、风险、适应症以及为何一种已退市。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating older opioid analgesics against modern targeted migraine therapies for pain management options.
结论
Lasmiditan is the available option for acute migraines while Propoxyphene is withdrawn and unsafe.
全部药物对比